.png)
Cnoga Medical
Non-invasive glucometer and 16-parameter blood/vitals monitor (TensorTip); needle-free remote monitoring
Vitality Radar
Pillar Analysis
Strategic Assessment
Strategic Vector
Cnoga Medical is positioned as a niche medical-device company centered on noninvasive glucose monitoring and adjacent biomarker/vitals wearables, with a clear emphasis on regulatory clearance and international commercialization. Its strategic direction appears to be broadening from glucose into multi-parameter digital health sensing while leveraging a long-running IP and clinical-validation narrative.[3][9][10]
Efficiency Ratio
The company shows strong technical and regulatory output relative to its visible public footprint, but limited evidence of scale-up signals such as active hiring, broad partner ecosystems, or high-velocity market expansion.[4][5][9]
Evidence Signals
Promoted the CoG Hybrid Non-Invasive Glucometer as a CE-approved device with hybrid non-invasive and invasive glucose measurement and HbA1c capability.
Marketed the Smart Capsule wearable sensor as a noninvasive biomarker and vital-sign monitoring platform with integration into smartwatches.
Company materials claim a 10-year presence in noninvasive glucose monitoring, an extended patent portfolio, and more than $70M in investments.
The CoG glucometer is described in medical and company materials as CE approved, with approval referenced for Europe and other international markets.
Company documentation states the device has been approved in 37 countries and that CNOGA has branch offices in China and Brazil.
Peer-reviewed publications describe the TensorTip Combo Glucometer as a Cnoga-developed noninvasive glucose prediction device using multiple optical signals and mathematical algorithms.
Scientific publication listings on the company site indicate an ongoing effort to support product claims with clinical and technical literature.
- About
- Israeli medical-device company (Cnoga Medical Ltd.; HQ Caesarea, Israel; founded 2004; founder Dr. Yosef Segman; ~51-200 staff; privately held, $70M+ invested) developing non-invasive, pain-free optical blood-monitoring devices and telemedicine. Its TensorTip family includes the Combo Glucometer (CoG) for needle-free glucose measurement and the TensorTip MTX/VSM, which measures ~16 blood/vital bio-parameters non-invasively in under a minute — cuffless blood pressure, hemoglobin, hematocrit, RBC, pulse, SpO2, pH, blood gases and hemodynamics (cardiac output, stroke volume, MAP) — plus a forthcoming 'Smart Capsule' wearable glucometer/biomarker sensor, all with mobile/web/cloud connectivity for remote patient monitoring. Devices are CE-certified as Class 2a (since May 2014) and ISO 13485 registered, with FDA marketing clearance for the blood-pressure/pulse (PPM) device; commercialized across Europe, Asia and South America (deployments incl. community clinics in Brazil and remote-monitoring projects in Puglia, Italy). Defense relevance: non-invasive continuous vitals/biomarker monitoring fits the casualty-monitoring cluster (peer to Biobeat/Neteera/CardiacSense), but Cnoga is civilian-first (diabetes/chronic-disease, home & rural telemedicine) with no defense credential.
- Tags
- #noninvasive #glucometer #biomarkers #vitalsigns #wearable #monitoring #ce #device #dualuse